» Articles » PMID: 36188032

Rosuvastatin Induced Photolocalized Purpura

Overview
Journal Clin Case Rep
Date 2022 Oct 3
PMID 36188032
Authors
Affiliations
Soon will be listed here.
Abstract

Statins are a widely used class of drug, usually safe and well-tolerated. Their cutaneous side effects are exceedingly rare. We describe a case of photoexposed purpuric eruption mediated by rosuvastatin.

References
1.
Adams A, Bobrove A, Gilliam A . Statins and "chameleon-like" cutaneous eruptions: simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man. J Cutan Med Surg. 2010; 14(5):207-11. DOI: 10.2310/7750.2010.09042. View

2.
Vesza Z, Pires C, da Silva P . Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment. Eur J Case Rep Intern Med. 2019; 5(5):000844. PMC: 6346926. DOI: 10.12890/2018_000844. View

3.
Forouzan P, Riahi R, Cohen P . Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events. Cureus. 2020; 12(3):e7155. PMC: 7108677. DOI: 10.7759/cureus.7155. View

4.
Rubegni P, Feci L, Pellegrino M, Fimiani M . Photolocalized purpura during levofloxacin therapy. Photodermatol Photoimmunol Photomed. 2012; 28(2):105-7. DOI: 10.1111/j.1600-0781.2012.00646.x. View

5.
Salna M, Singer H, Dana A . Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis. Case Rep Dermatol Med. 2017; 2017:3418204. PMC: 5555012. DOI: 10.1155/2017/3418204. View